Genvec Inc (GNVC) financial statements (2022 and earlier)

Company profile

Business Address 910 CLOPPER ROAD
GAITHERSBURG, MD 20878
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3,6677,0157,9685,24915,255
Cash and cash equivalents3,6677,0157,9685,2494,150
Short-term investments    11,105
Receivables22166325201947
Prepaid expense and other current assets226
Other undisclosed current assets3,7691,9066,9431,193 
Total current assets:7,4589,08715,2366,64316,428
Noncurrent Assets
Property, plant and equipment191279276514805
Restricted cash and investments   97 
Other noncurrent assets589797 
Prepaid expense and other noncurrent assets197
Total noncurrent assets:2493763736111,002
TOTAL ASSETS:7,7079,46315,6097,25417,430
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,8471,6942,2221,9532,990
Accounts payable9571,0961,1461,0481,500
Accrued liabilities206148474  
Employee-related liabilities6844506029051,490
Deferred revenue and credits    4
Other undisclosed current liabilities   691693
Total current liabilities:1,8471,6942,2222,6443,687
Noncurrent Liabilities
Liabilities, other than long-term debt968989  
Other liabilities968989  
Other undisclosed noncurrent liabilities1,059    
Total noncurrent liabilities:1,1558989  
Total liabilities:3,0021,7832,3112,6443,687
Stockholders' equity
Stockholders' equity attributable to parent4,7057,68013,2984,61013,743
Common stock217171413
Additional paid in capital295,333292,508291,609280,398279,518
Accumulated other comprehensive loss(3)(5)(33)(22)(27)
Accumulated deficit(290,627)(284,840)(278,295)(275,780)(265,761)
Total stockholders' equity:4,7057,68013,2984,61013,743
TOTAL LIABILITIES AND EQUITY:7,7079,46315,6097,25417,430

Income statement (P&L) ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues5118856,0413,6829,353
Revenue, net5118856,041  
Gross profit:5118856,0413,6829,353
Operating expenses(7,726)(7,452)(8,578)(13,976)(23,450)
Operating loss:(7,215)(6,567)(2,537)(10,294)(14,097)
Nonoperating income1,428   42
Net loss:(5,787)(6,567)(2,537)(10,294)(14,055)
Other undisclosed net income attributable to parent 2222275 
Net loss available to common stockholders, diluted:(5,787)(6,545)(2,515)(10,019)(14,055)

Comprehensive Income ($ in thousands)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(5,787)(6,567)(2,537)(10,294)(14,055)
Comprehensive loss:(5,787)(6,567)(2,537)(10,294)(14,055)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent25011280(19)
Comprehensive loss, net of tax, attributable to parent:(5,785)(6,517)(2,526)(10,014)(14,074)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: